Pharma

shadow follow leader
Pharma

Argenx reports Q3 sales bump and a new trial requirement

Argenx's third-quarter Vyvgart sales surge was overshadowed by high operating expenses and a confirmatory trial requirement from the FDA.
Donavyn Coffey Oct 23, 2026 11:42am
Texas Texas gavel gavel Texas law Texas court TX Attorney General Texas AG Ken Paxton

Gilead to pay $45M to resolve kickback allegations in Texas

Oct 23, 2026 10:57am
Why Are 53 of Phase 2 and 3 Trials Delayed A Redesign Is Overdue

Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue

Brought to you by Bain & Company
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly, Novo see script dip amid holiday

Oct 23, 2026 9:51am
video
Why AIs Biggest Value in Pharma Is Confidence

Why AI’s Biggest Value in Pharma Is Confidence

Brought to you by /prompt
Podcast
Fierces The Top Line logo appears over a pale yellow background patterned with diagonal yellow capsules

GSK's twin FDA wins, Roche's $15B deal and point-of-care ads

Oct 23, 2026 9:28am